Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
484 Preliminary efficacy of the IL-15 superagonist SO-C101 in combination with pembrolizumab in patients with advanced/metastatic solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.